Liposomal amikacin for inhalation

DRUG3 trials

Sponsors

Insmed Incorporated

Conditions

Cystic FibrosisHealthy Volunteers

Phase 1

A Study to Investigate Lung Deposition of Inhaled Amikacin-loaded Liposomes in Healthy Male Participants

CompletedNCT05999942

Insmed IncorporatedHealthy Volunteers

Start: 2004-06-02End: 2004-06-29Updated: 2023-08-21

Phase 3

Study to Evaluate Arikace™ in CF Patients With Chronic Infection Due to Pseudomonas Aeruginosa

WithdrawnNCT01315691

Insmed IncorporatedCystic Fibrosis

Updated: 2018-07-31

Extension Study of Liposomal Amikacin for Inhalation in Cystic Fibrosis (CF) Patients With Chronic Pseudomonas Aeruginosa (Pa) Infection

CompletedNCT01316276

Insmed IncorporatedCystic Fibrosis

Start: 2012-10-05End: 2015-07-16Updated: 2020-06-17

Related Papers

Long-term amikacin liposome inhalation suspension in cystic fibrosis patients with chronic P. aeruginosa infection.

2021-06-1619 citations

LAI Improves Pulmonary Function in CF

MD Conference Express2014-08-01